Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
accessible, accompanying, advance, Aegerion, affirmed, Allergan, America, Amgen, Aqua, Array, asserted, autoimmune, autoimmunity, Bangalore, Bay, Bio, BioPharma, biotech, BRCA, Brilinta, Brilique, bring, CAD, Canadian, capitalised, Caprelsa, challenging, Cilag, Codification, Commonwealth, concluded, concluding, concurrent, conformity, consulted, Consumer, context, Crestor, deduction, demand, discipline, divestment, drove, earned, Eastern, efficiency, Elan, encountered, enema, ensuring, Entocort, epithelial, error, evidence, examining, facility, factor, factored, fallopian, Farxiga, fewer, Florida, flow, FluMist, Forxiga, fraud, Genzyme, Great, grew, healthcare, hold, HPV, Imdur, Imfinzi, India, inflammation, introductory, inventory, invoiced, IQVIA, Iressa, Japan, Kentucky, Korea, krona, largest, Latin, leader, licence, liquidity, local, longer, Losec, lung, MEK, Ministry, mirrored, misstatement, movement, MSD, mutation, Myalept, NSCLC, omitted, Oncology, ovarian, partly, PCAOB, people, peritoneal, Perrigo, pivotal, Platform, potential, pound, pretrial, proceed, professional, programme, provision, Pty, Pulmicort, quality, quantification, radiation, rare, redeploy, relapsed, rendered, Return, revaluation, Rhinocort, safe, scheduled, selumetinib, sending, sharper, specialty, spinning, split, stable, stake, sterling, streamlining, strong, Sweden, Swedish, Symbicort, Tagrisso, Taiwan, Takeda, term, textual, tube, type, unaudited, unsolicited, vaccine, Viela, volume, written
Removed:
AGM, Amendment, appeal, backup, Bank, Cautionary, Chase, denied, duty, expressed, extent, hereto, IMS, inheritance, injunction, January, JPMorgan, launch, lawsuit, lesser, license, LLC, Measuring, medical, Morgan, motion, Passive, PFIC, predecessor, reserve, retain, safety, September, stamp, succeeded, University, withholding, Zeneca
Filing tables
Filing exhibits
AZN similar filings
Filing view
External links
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statement on Form F-3 (No. 333-214756) and Form S-8 (No. 333-216901; No. 333-170381; No. 333-152767; No.333-124689; and No. 333-09062) of AstraZeneca PLC of our report dated February 2, 2018 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F.
/s/ PricewaterhouseCoopers LLP |
|
|
|
London, United Kingdom |
|
March 6, 2018 |
|